Zobrazeno 1 - 10
of 601
pro vyhledávání: '"J Goudemand"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Goudemand, C. Laurendeau, M Trossaert, R. Varin, C. Godard, F. Hadim, B. Detournay, B. Polack
Publikováno v:
The European Journal of Health Economics. 23:23-32
The Hemraude study was conducted to describe the profile of patients with HA, disease management, and economic burden in a collective perspective. This retrospective study was conducted using the French administrative healthcare claims database SNIIR
Publikováno v:
Archives de Pédiatrie. 28:156-158
Background The range of normal values for coagulation factors in the healthy newborn was described 30 years ago but since then the reagents, automated systems, and dosing techniques have changed considerably. For 30 years, several authors have tried
Publikováno v:
65th Annual Meeting of the Society of Thrombosis and Haemostasis Research.
Publikováno v:
65th Annual Meeting of the Society of Thrombosis and Haemostasis Research.
Autor:
C, Laurendeau, J, Goudemand, M, Trossaert, B, Polack, R, Varin, C, Godard, F, Hadim, B, Detournay
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care. 23(1)
The Hemraude study was conducted to describe the profile of patients with HA, disease management, and economic burden in a collective perspective.This retrospective study was conducted using the French administrative healthcare claims database SNIIRA
Autor:
C. Godard, Marc Trossaert, C. Laurendeau, F. Hadim, B. Detournay, B. Polack, R. Varin, J. Goudemand
Publikováno v:
Value in Health. 23:S702-S703
Autor:
C. Laurendeau, B. Detournay, Marc Trossaert, B. Polack, R. Varin, J. Goudemand, C. Godard, F. Hadim
Publikováno v:
Value in Health. 23:S695
Autor:
Christine Vinciguerra, Hervé Chambost, J. Goudemand, Yoann Huguenin, Virginie Demiguel, Patrice Lutz, Thierry Calvez, Chantal Rothschild, Alexandra Doncarli, Roseline d'Oiron, Yves Gruel, Vincent Dalibard
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2017, 103 (1), pp.179-189
Haematologica, 2018, 103 (1), pp.179-189. ⟨10.3324/haematol.2017.174706⟩
Haematologica 1 (103), 179-189. (2018)
Haematologica, Ferrata Storti Foundation, 2018, 103 (1), pp.179-189. ⟨10.3324/haematol.2017.174706⟩
Haematologica, Ferrata Storti Foundation, 2017, 103 (1), pp.179-189
Haematologica, 2018, 103 (1), pp.179-189. ⟨10.3324/haematol.2017.174706⟩
Haematologica 1 (103), 179-189. (2018)
Haematologica, Ferrata Storti Foundation, 2018, 103 (1), pp.179-189. ⟨10.3324/haematol.2017.174706⟩
International audience; A round one third of boys with severe hemophilia A develop inhibitors (neutralizing antibodies) against their therapeutic factor VIII product. This adverse effect may result in more lifethreatening bleeding, disability, impair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c2bcc1ed1dc098b6cd47b76d0d2bdf
https://hal.univ-brest.fr/hal-02052359
https://hal.univ-brest.fr/hal-02052359
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.